InsidersTradesSigma
Track the 이지바이오 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Food & Beverage sector, 이지바이오 has published 2 insider filings. Market capitalisation: €199.8bn. The latest transaction was reported on 17 March 2026 (Other). Among the most active insiders: 이지바이오. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
이지바이오 是一家专注于农业食品领域的公司，在 XKRX 市场上市。它致力于有机产品的开发和分销。